Medication nonadherence among people with chronic obstructive pulmonary disease (COPD) is a result of affordability and lack of knowledge about medications, among other factors, and leads to increased ...
Mepolizumab reduces moderate to severe COPD exacerbations in patients with varying blood eosinophil counts and type 2 ...
Medication nonadherence among people with chronic obstructive pulmonary disease (COPD) is a result of affordability and lack of knowledge about medications, among other factors, and leads to increased ...
News-Medical.Net on MSN
Sustainable inhalers offer better outcomes for COPD patients
New research from UCLA Health suggests that certain inhalers used to treat chronic obstructive pulmonary disease (COPD) are ...
Umeclidinium-vilanterol is associated with improved clinical outcomes in symptomatic patients with chronic obstructive pulmonary disease.
Struggling to fall asleep and stopping breathing at night may be a far riskier combo than previously thought. In a study of ...
1don MSN
Intranasal vaccine booster shows stronger immune response and protection against sarbecoviruses
Researchers at the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) and Monash University in ...
Obesity research has become increasingly relevant as global rates of overweight and obesity continue to rise, affecting all age groups and communities.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results